An estrogen receptor antagonist, Fulvestrant is used for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women. It is administered intramuscularly. Reference standards of Fulvestrant API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Fulvestrant (Y0001399) [catalogue_number] => PA EPY0001399 [category_ids] => ,150, [chemical_name] => [weight] => NA [form] => NA [cas] => NA [pslug] => fulvestrant-y0001399-paepy0001399 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA EPY0001399
CAS :
Molecular Formula : NA
Molecular Weight : NA
stdClass Object ( [pname] => Fulvestrant for system suitability (Y0001413) [catalogue_number] => PA EPY0001413 [category_ids] => ,150, [chemical_name] => [weight] => NA [form] => NA [cas] => NA [pslug] => fulvestrant-for-system-suitability-y0001413-paepy0001413 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA EPY0001413
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
